½ÃÀ庸°í¼­
»óǰÄÚµå
1288641

¼¼°èÀÇ Àڱ⠺ñÁî ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2030³â)

Global Magnetic Beads Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 215 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àڱ⠺ñÁî ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023-2030³âÀÇ Á¶»ç ±â°£ Áß CAGR 26.62%·Î 2022³â 50¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â ¾à 420¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î Ãß»êµË´Ï´Ù.

Àڱ⠺ñÁî´Â »êȭö, Æä¶óÀÌÆ®, ´ÏÄÌ µî ´Ù¾çÇÑ Àç·á·Î ¸¸µé¾îÁø ÀÛÀº ±¸Çü ÀÔÀÚÀÔ´Ï´Ù. ´Ü¹éÁúÀ̳ª ÇÙ»ê°ú °°Àº ƯÁ¤ »ýü ºÐÀÚ¿Í °áÇÕÇÒ ¼ö ÀÖµµ·Ï ±â´ÉÈ­µÈ Ç¥¸éÃþÀ¸·Î ÄÚÆÃµÇ¾î ÀÖ½À´Ï´Ù. Àڱ⠺ñÁî´Â Áø´Ü Å×½ºÆ®, ´Ü¹éÁú Á¤Á¦, ¼¼Æ÷ ºÐ¸®, ½Å¾à °³¹ß µî »ý¸í°úÇÐ ºÐ¾ß¿¡¼­ ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Àڱ⠺ñÁî´Â ±âÁ¸ ¹æ¹ý¿¡ ºñÇØ ¼Óµµ, °¨µµ, ƯÀ̼º µî ¸î °¡Áö ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. Àڱ⠺ñÁî´Â ÀÚ±âÀåÀ» ÀÌ¿ëÇÏ¿© ºñµå¸¦ ²ø¾î´ç°Ü ½Ã·á¿¡¼­ ºÐ¸®ÇÏ´Â Àڱ⠺и®±â¿Í ÇÔ²² »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. Àڱ⠺ñÁîÀÇ Å©±â¿Í Ç¥¸é È­ÇÐÀû Ư¼ºÀº ƯÁ¤ ¿ëµµ¿¡ ¸Â°Ô Á¶Á¤ÇÒ ¼ö ÀÖÀ¸¸ç, ³ôÀº ƯÀ̼º°ú °¨µµ¸¦ ´Þ¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àڱ⠺ñÁî´Â ´ë·®ÀÇ ½Ã·á¸¦ ºü¸£°í Á¤È®ÇÏ°Ô Ã³¸®ÇØ¾ß ÇÏ´Â °í󸮷® ÀÀ¿ë ºÐ¾ß¿¡µµ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

Àڱ⠺ñÁî´Â ÇÙ»ê ºÐ¸®, ´Ü¹éÁú ºÐ¸®, ¼¼Æ÷ ºÐ¸® µî ´Ù¾çÇÑ Áø´Ü ºÐ¾ß¿¡ »ç¿ëµË´Ï´Ù. Áø´Ü Å×½ºÆ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÀÀ¿ë ºÐ¾ß¿¡ »ç¿ëµÇ´Â Àڱ⠺ñÁî¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àڱ⠺ñÁî´Â »ý¸í°øÇÐ ¹× Á¦¾à »ê¾÷¿¡¼­ ½Å¾à °³¹ß, Á¤Á¦ ¹× ºÐ¼®¿¡ »ç¿ëµË´Ï´Ù. ½Å¾à°ú Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ È°µ¿À» Áö¿øÇÏ´Â Àڱ⠺ñÁî¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ´õ ³ôÀº °¨µµ¿Í ƯÀ̼º, ´õ ºü¸¥ ºÐ¸® ½Ã°£, ´õ »ç¿ëÇϱ⠽¬¿î Àڱ⠺ñÁî Á¦Ç°ÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ Àڱ⠺ñÁî¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ºÐ¾ßÀÇ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ´Ù¾çÇÑ ¿¬±¸ ¿ëµµ¿¡ »ç¿ëµÇ´Â Àڱ⠺ñÁî¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áß±¹, Àεµ¿Í °°ÀÌ °æÁ¦°¡ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ´Â Áö¿ª¿¡¼­´Â Àڱ⠺ñÁîÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ Áö¿ª ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àڱ⠺ñÁî´Â °³Àκ° À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏÀ» ±â¹ÝÀ¸·Î ȯÀÚ ¸ÂÃãÇü Ä¡·á¹ýÀ» °³¹ßÇÏ´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÌ·¯ÇÑ ¿ëµµ¿¡ »ç¿ëµÇ´Â Àڱ⠺ñÁî ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â Portre's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·Âµµ¸¦ Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº ¼¼°è Àڱ⠺ñÁî ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àڱ⠺ñÁî »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº º» ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ªº° ºÐ¼® :

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áß³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àڱ⠺ñÁî ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÌ Á¶»ç º¸°í¼­´Â ½ÃÀå ÁÖ¿ä ±â¾÷ÀÇ Á¾ÇÕÀû °³¿ä¿Í ¼¼°è °æÀï ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °üÁ¡À» ´Ù·ç°í ÀÖ½À´Ï´Ù. Àڱ⠺ñÁî ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Thermo Fisher Scientific Inc. Laboratories Inc, Miltenyi Biotec, Ferrotec(USA) Corporation, Eurofins Technologies, Micromod Partikeltechnologie GmbH, New England Biolabs, Rockland Immunochemicals Inc, Dimunicon Corp, Magnetically Delivered Therapeutics Inc. µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ÁÖ¿ä M&A, ¹Ì·¡ ¿ª·®, ÆÄÆ®³Ê½Ê, À繫 °³¿ä, Çù¾÷, ½ÅÁ¦Ç° Çù¾÷, ½ÅÁ¦Ç° °³¹ß, ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ Àü·«Àû ¹ßÀüÀ» Æ÷ÇÔÇÑ °æÀï ±¸µµÀÇ ÀüüÀûÀÎ °üÁ¡À¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

  • º» º¸°í¼­ÀÇ ³»¿ë
    • ¸ñÀû
    • ´ë»ó µ¶ÀÚ
    • USP(Unique Selling Proposition)¿Í Á¦°ø
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • ½ÃÀå Á¶»ç ÇÁ·Î¼¼½º
    • ½ÃÀå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀåÀÇ ½º³À¼ô

Á¦3Àå Àڱ⠺ñÁî - »ê¾÷ ºÐ¼®

  • ¼­·Ð - ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • »ê¾÷ µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
    • À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÀÚ¼ºÃ¼ Äھ
    • ½ÃÀ庰 ¸Å·Â ºÐ¼® : »çÀÌÁ
    • ½ÃÀ庰 ¸Å·Â ºÐ¼® : ¾ÖÇø®ÄÉÀ̼Ǻ°
    • ½ÃÀ庰 ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³ÎÀÇ µ¿Çâ

Á¦5Àå COVID-19 ¹ß»ýÀÇ ¿µÇ⠺м®

Á¦6Àå ¼¼°èÀÇ Àڱ⠺ñÁî ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • À¯Çüº° ºÐ¼®
  • ¸é¿ªÄ§°­
  • ¼¼Æ÷
  • º´¿ø¼º ¹Ì»ý¹°
  • ÇÙ»ê
  • ÆéƼµå
  • ´Ü¹éÁú
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Àڱ⠺ñÁî ½ÃÀå ºÐ¼® : ÀÚ¼ºÃ¼ Äھ

  • ÀÚ¼ºÃ¼ Äھ °³¿ä
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • ÀÚ¼ºÃ¼ Äھ ºÐ¼®
  • ÃÊ»óÀÚ¼º
  • Æä¸®¸¶±×³×ƽ

Á¦8Àå ¼¼°èÀÇ Àڱ⠺ñÁî ½ÃÀå ºÐ¼® : »çÀÌÁ

  • »çÀÌÁ °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • »çÀÌÁ ºÐ¼®
  • 5¥ìm ¹Ì¸¸
  • 5-20¥ìm
  • 20-40¥ìm
  • 40¥ìm ÀÌ»ó

Á¦9Àå ¼¼°èÀÇ Àڱ⠺ñÁî ½ÃÀå ºÐ¼® : ¾ÖÇø®ÄÉÀ̼Ǻ°

  • °³¿ä : ¾ÖÇø®ÄÉÀ̼Ǻ°
  • ½ÇÀû°ú ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¾ÖÇø®ÄÉÀ̼Ǻ°
  • ¹ÙÀÌ¿À¸®¼­Ä¡
  • ü¿ÜÁø´Ü¾à
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ Àڱ⠺ñÁî ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ¿ª»ç Àû¡¤¿¹ÃøÀû ÆÇ¸Å ºÐ¼®
    • ºÏ¹Ì ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • ºÏ¹Ì ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • ¹Ì±¹ÀÇ ÆÇ¸Å ºÐ¼®
    • ij³ª´ÙÀÇ ÆÇ¸Å ºÐ¼®
    • ¸ß½ÃÄÚÀÇ ÆÇ¸Å ºÐ¼®
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ¿ª»ç Àû¡¤¿¹ÃøÀû ÆÇ¸Å ºÐ¼®
    • À¯·´ÀÇ ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • À¯·´ÀÇ ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • ¿µ±¹ÀÇ ÆÇ¸Å ºÐ¼®
    • ÇÁ¶û½ºÀÇ ÆÇ¸Å ºÐ¼®
    • µ¶ÀÏÀÇ ÆÇ¸Å ºÐ¼®
    • ÀÌÅ»¸®¾ÆÀÇ ÆÇ¸Å ºÐ¼®
    • ·¯½Ã¾ÆÀÇ ÆÇ¸Å ºÐ¼®
    • ±âŸ À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ¿ª»ç Àû¡¤ÇâÈÄÆÇ¸Å°í ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • Áß±¹ÀÇ ÆÇ¸Å ºÐ¼®
    • ÀεµÀÇ ÆÇ¸Å ºÐ¼®
    • ÀϺ»ÀÇ ÆÇ¸Å ºÐ¼®
    • Çѱ¹ÀÇ ÆÇ¸Å ºÐ¼®
    • È£ÁÖÀÇ ÆÇ¸Å ºÐ¼®
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ¿ª»ç Àû¡¤ÇâÈÄÆÇ¸Å°í ºÐ¼®
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • ºê¶óÁúÀÇ ÆÇ¸Å ºÐ¼®
    • ¾Æ¸£ÇîÆ¼³ªÀÇ ÆÇ¸Å ºÐ¼®
    • Æä·çÀÇ ÆÇ¸Å ºÐ¼®
    • Ä¥·¹ÀÇ ÆÇ¸Å ºÐ¼®
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ¿ª»ç Àû¡¤ÇâÈÄÆÇ¸Å°í ºÐ¼®
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ ÆÇ¸Å ºÐ¼®
    • UAEÀÇ ÆÇ¸Å ºÐ¼®
    • À̽º¶ó¿¤ÀÇ ÆÇ¸Å ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ ÆÇ¸Å ºÐ¼®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®

Á¦11Àå Àڱ⠺ñÁî ±â¾÷ÀÇ °æÀï ±¸µµ

  • Àڱ⠺ñÁî ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Çù¾÷/ÇùÁ¤
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦12Àå ±â¾÷ °³¿ä

  • TOP ±â¾÷ÀÇ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Thermo Fisher Scientific Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° ¼Ò°³
    • ÃÖ±Ù °³¹ß »óȲ
  • Merck KGaA
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Bangs Laboratories Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Spherotech Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • GenScript
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • CardioGenics Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Bio-Rad Laboratories Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Miltenyi Biotec
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Ferrotec(USA) Corporation
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Eurofins Technologies
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Micromod Partikeltechnologie GmbH
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • New England Biolabs
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Rockland Immunochemicals Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Dynal Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Promega
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Ferrofluidics
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Immunicon Corp
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Magnetically Delivered Therapeutics Inc.
    • ȸ»ç °³¿ä
    • ±â¾÷ ¸ÅÃâ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù µ¿Çâ

ÁÖ : ±â¾÷ °³¿ä¿¡¼­ À繫ÀÇ »ó¼¼ ³»¿ª°ú Ãֽа³¹ßÀº ÀÔ¼ö »óȲ¿¡ µû¶ó Á¦°ø °¡´ÉÇϳª ºñ°ø°³ ȸ»çÀÇ °æ¿ì, ´Ù·çÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.

KSA 23.07.05

The global demand for Magnetic Beads Market is presumed to reach the market size of nearly USD 42 BN by 2030 from USD 5.02 BN in 2022 with a CAGR of 26.62% under the study period 2023-2030.

Magnetic beads are small, spherical particles made from a variety of materials, such as iron oxide, ferrite, or nickel. They are coated with a functionalized surface layer that can bind to specific biological molecules, such as proteins or nucleic acids. Magnetic beads are used in a wide range of applications in the life sciences, including diagnostic tests, protein purification, cell separation, and drug discovery. They offer several advantages over traditional methods, such as speed, sensitivity, and specificity. Magnetic beads are often used in combination with magnetic separators, which use a magnetic field to attract the beads and separate them from the sample. The size and surface chemistry of the magnetic beads can be tailored to specific applications, allowing for high specificity and sensitivity. Magnetic beads can also be used in high-throughput applications where large numbers of samples need to be processed quickly and accurately.

Market Dynamics:

Magnetic beads are used in a wide range of diagnostic applications, including nucleic acid isolation, protein isolation, and cell separation. With the growing demand for diagnostic tests, there is an increasing demand for magnetic beads for use in these applications. Magnetic beads are also used in the biotechnology and pharmaceutical industries for drug discovery, purification, and analysis. With the increasing demand for new drugs and therapies, there is a growing demand for magnetic beads to support these activities. Technology advancements have led to advanced magnetic bead products that offer higher sensitivity and specificity, faster isolation times, and greater ease of use. This has further increased the demand for magnetic beads in various applications. The growing focus on research and development activities in the life sciences has led to an increasing demand for magnetic beads for use in various research applications. The increasing adoption of magnetic beads in upcoming economies of China and India is driving the market in these regions. Magnetic beads are also used in personalized medicine, where patient-specific treatments are developed based on an individual's unique genetic profile. With the growing interest in personalized medicine, there is an increasing demand for magnetic beads for use in these applications.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of magnetic beads. The growth and trends of magnetic beads industry provide a holistic approach to this study.

Market Segmentation:

This section of the magnetic beads market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Immunoprecipitation
  • Cells
  • Pathogenic Microorganisms
  • Nucleic Acids
  • Peptide
  • Protein
  • Others

By Magnetic Core

  • Superparamagnetic
  • Ferrimagnetic

By Size

  • Less Than 5 Mm
  • 5-20 Mm
  • 20-40 Mm
  • 40 Mm And Above

By Application

  • Bioresearch
  • In-Vitro Diagnostics
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Magnetic Beads market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the magnetic beads market include Thermo Fisher Scientific Inc., Merck KGaA, Bangs Laboratories Inc., Spherotech Inc., GenScript, CardioGenics Inc., Bio-Rad Laboratories Inc., Miltenyi Biotec, Ferrotec (USA) Corporation, Eurofins Technologies, Micromod Partikeltechnologie GmbH, New England Biolabs, Rockland Immunochemicals Inc., Dynal Inc., Promega, Ferrofluidics, Immunicon Corp, Magnetically Delivered Therapeutics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MAGNETIC BEADS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Magnetic Core
    • 3.7.3 Market Attractiveness Analysis By Size
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MAGNETIC BEADS MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Immunoprecipitation Historic and Forecast Sales by Regions
  • 6.5 Cells Historic and Forecast Sales by Regions
  • 6.6 Pathogenic Microorganisms Historic and Forecast Sales by Regions
  • 6.7 Nucleic Acids Historic and Forecast Sales by Regions
  • 6.8 Peptide Historic and Forecast Sales by Regions
  • 6.9 Protein Historic and Forecast Sales by Regions
  • 6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL MAGNETIC BEADS MARKET ANALYSIS BY MAGNETIC CORE

  • 7.1 Overview by Magnetic Core
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Magnetic Core
  • 7.4 Superparamagnetic Historic and Forecast Sales by Regions
  • 7.5 Ferrimagnetic Historic and Forecast Sales by Regions

8 . GLOBAL MAGNETIC BEADS MARKET ANALYSIS BY SIZE

  • 8.1 Overview by Size
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Size
  • 8.4 Less Than 5 ¥ìm Historic and Forecast Sales by Regions
  • 8.5 5-20 ¥ìm Historic and Forecast Sales by Regions
  • 8.6 20-40 ¥ìm Historic and Forecast Sales by Regions
  • 8.7 40 ¥ìm And Above Historic and Forecast Sales by Regions

9 . GLOBAL MAGNETIC BEADS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Bioresearch Historic and Forecast Sales by Regions
  • 9.5 In-vitro Diagnostics Historic and Forecast Sales by Regions
  • 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL MAGNETIC BEADS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE MAGNETIC BEADS COMPANIES

  • 11.1. Magnetic Beads Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF MAGNETIC BEADS INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Merck KGaA
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Bangs Laboratories Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Spherotech Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. GenScript
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. CardioGenics Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Bio-Rad Laboratories Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Miltenyi Biotec
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Ferrotec (USA) Corporation
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Eurofins Technologies
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Micromod Partikeltechnologie GmbH
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. New England Biolabs
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Rockland Immunochemicals Inc.
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Dynal Inc.
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. Promega
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Ferrofluidics
    • 12.18.1. Company Overview
    • 12.18.2. Company Revenue
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. Immunicon Corp
    • 12.19.1. Company Overview
    • 12.19.2. Company Revenue
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. Magnetically Delivered Therapeutics Inc.
    • 12.20.1. Company Overview
    • 12.20.2. Company Revenue
    • 12.20.3. Products
    • 12.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦